cytoimmune-logocytoimmune-logocytoimmune-logocytoimmune-logo
  • About Us
    • Our Story
    • Leadership
    • Board of Directors
  • Our Science
    • Overview
    • Platform and Programs
    • Manufacturing
  • Our Pipeline
  • Investors & Media
    • Company Overview
    • Press Releases
    • Events and Presentations
    • Publications
    • FAQs
  • Careers
  • Contact Us

Test Page

Events and Presentations

May 4, 2022

CytoImmune CEO Dr. Christina Coughlin to Participate in “The Cell Therapy Landscape | CAR-T to Stem Cells” at the World Medical Innovation Forum

April 25, 2022

Chardan Annual Genetic Medicines & Cell Therapy Manufacturing Summit (fireside chat) at 9:00 a.m. ET.

April 14, 2022

Needham 21st Annual Virtual Healthcare Conference’s “NK Therapeutics Panel” at 11:45 a.m. ET

April 11, 2022

CytoImmune will present at the Locust Walk Stem Cell Tx Conference in Partnership with Harvard Stem Cell Institute

February 9, 2022

CytoImmune Therapeutics to Participate in the 2022 BIO CEO & Investor Conference and the SVB Leerink Global Healthcare Conference

November 9, 2021

CytoImmune will participate in the Stifel 2021 Virtual Healthcare Conference

September 5, 2021

CytoImmune Therapeutics | Wells Fargo Healthcare Conference

July 16, 2021

CytoImmune Therapeutics, Inc. CMO Michael Caligiuiri, MD to Present at a KOL Webinar on Human Natural Killer (NK) Cell Immunotherapy

July 16, 2021

CytoImmune Therapeutics, Inc. President William Rosellini to Present at Upcoming Conferences

Load more

Contact Us

1218 S 5th Ave,
Monrovia, CA 91016
General information:
info@cytoimmune.com
Investors:
ir@cytoimmune.com



  • Home
  • About us
  • Our Science
  • Our Pipeline
  • Investors and Media
  • Careers
  • Contact
  • Terms of use
  • Privacy Policy
© 2022 Cytoimmune Therapeutics | All Rights Reserved
© 2022 Cytoimmune Therapeutics | All Rights Reserved